Lucy Gao
About
Research
Publications
2025
Prolonged Hospitalization for Hematopoietic Cell Transplantation: Characteristics, Risk Factors and Associations with Patient-Reported and Clinical Outcomes
Gao L, Nelson A, Barata A, Horick N, Wekwerth B, Wood A, Fernandes A, Lee S, LeBlanc T, Amonoo H, El-Jawahri A, Newcomb R. Prolonged Hospitalization for Hematopoietic Cell Transplantation: Characteristics, Risk Factors and Associations with Patient-Reported and Clinical Outcomes. Transplantation And Cellular Therapy 2025, 31: 697.e1-697.e12. PMID: 40505814, PMCID: PMC12357325, DOI: 10.1016/j.jtct.2025.05.026.Peer-Reviewed Original ResearchPatient-reported outcomesProlonged length of staySymptom burdenDepressive symptomsYears post-HCTSpecialty palliative careSecondary analysis of dataHigh risk of prolonged length of stayMonths post-HCTGreater healthcare utilizationCox proportional hazards regressionIncreased risk of mortalityAssociated with higher riskQuality of lifeProportional hazards regressionMultivariate logistic regressionRisk of rehospitalizationPosttraumatic stress symptomsRisk of mortalityPalliative careRisk of prolonged length of stayAssociated with prolonged length of stayDepression burdenHealthcare utilizationLength of stay
2024
Trajectories of patient-reported outcomes after prolonged stays for hematopoietic cell transplant.
Gao L, DeFilipp Z, Chen Y, Lee S, LeBlanc T, Amonoo H, El-Jawahri A, Newcomb R. Trajectories of patient-reported outcomes after prolonged stays for hematopoietic cell transplant. Journal Of Clinical Oncology 2024, 42: 6553-6553. DOI: 10.1200/jco.2024.42.16_suppl.6553.Peer-Reviewed Original ResearchHematopoietic cell transplantationProlonged length of stayAllogeneic hematopoietic cell transplantationPosttraumatic stress disorderBaseline to week 2Patient-reported outcomesDepressive symptomsQuality of lifeWeek 2Cell transplantationAcute leukemiaChronic graft-versus-host diseaseGraft-versus-host diseaseAutologous hematopoietic cell transplantationYears of hematopoietic cell transplantationProspective study of patientsPsychological distressPosttraumatic stress disorder symptomsRate of relapseMonths post-HCTStudy of patientsMultivariate logistic regressionAssociated with greater oddsLength of stayIncreased psychological distressOutcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects
Newcomb R, Gao L, Vanderklish J, Tse A, Saylor M, Danielson C, Wali N, Frigault M, McAfee S, Spitzer T, DeFilipp Z, Chen Y, Amonoo H, El-Jawahri A. Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects. Transplantation And Cellular Therapy 2024, 30: 700-711. PMID: 38685402, PMCID: PMC11223964, DOI: 10.1016/j.jtct.2024.04.018.Peer-Reviewed Original ResearchConceptsHematopoietic cell transplantationAllogeneic hematopoietic cell transplantationPromote screening adherencePost-HCTScreening adherenceCell transplantationPost-transplant complicationsSurvivorship programsCox proportional hazards regressionProportion of patientsPulmonary function testsProportional hazards regressionEndocrine evaluationMedian timeSecondary cancersRetrospective analysisEvaluate efficacyPrimary outcomeHazards regressionFunction testsPatientsLate effectsScreening outcomesScreening domainsTransfer careSearching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)
Gao L, Medford A, Spring L, Bar Y, Hu B, Jimenez R, Isakoff S, Bardia A, Peppercorn J. Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA). Breast Cancer Research And Treatment 2024, 205: 211-226. PMID: 38355821, DOI: 10.1007/s10549-024-07253-6.Peer-Reviewed Original ResearchConceptsCirculating tumor DNABreast cancer careSystemic therapyTumor DNABreast cancerBreast cancer recurrence riskRisk of recurrenceCancer careCancer recurrence riskCirculating Tumor CellsNarrative reviewTreat many patientsBreast cancer evaluationDistant diseaseFear of recurrenceBreast oncologistsPredictive biomarkersRecurrence riskTumor cellsCancer evaluationImprove prognosticationClinical challengeTreatment selectionPatientsBreastEffect of Hematopoietic Cell Transplant (HCT) Survivorship Program on Screening for Late Effects over Time
Newcomb R, Gao L, Vanderklish J, Saylor M, Danielson C, Wali N, DeFilipp Z, Chen Y, Amonoo H, El-Jawahri A. Effect of Hematopoietic Cell Transplant (HCT) Survivorship Program on Screening for Late Effects over Time. Transplantation And Cellular Therapy 2024, 30: s343-s344. DOI: 10.1016/j.jtct.2023.12.479.Peer-Reviewed Original ResearchHematopoietic cell transplantationProportion of patientsPost-HCTYears post-HCTSurvivorship programsCare modelAllogeneic hematopoietic cell transplantationMedical screeningGVHD prophylaxis regimenHCT-CI scorePost-transplant cyclophosphamideSurvivorship care modelsEffects of hematopoietic cell transplantationHematopoietic cell transplantation survivorsElectronic health recordsMultivariate logistic regressionStudy periodEffects over timeHCT-CIOphthalmologic examScreening discussionsDisease relapseProphylaxis regimenCell transplantationLate treatment effects
2023
Intravascular Lymphoma as a Cause of Recurrent Strokes – Case Report and Review of the Literature
Zhao C, Fan T, Denize T, Coraini A, Kraft A, Kumar A, Gao L, Lorenzo M, Duncan L, Faye E, Lin D. Intravascular Lymphoma as a Cause of Recurrent Strokes – Case Report and Review of the Literature. The Neurohospitalist 2023, 13: 419-424. PMID: 37701250, PMCID: PMC10494820, DOI: 10.1177/19418744231183483.Peer-Reviewed Original ResearchIntravascular lymphomaCase reportPotential etiologiesRisk factorsSpinal cord infarctionMultiple cardiovascular risk factorsTreated with methotrexateRecurrent strokeIrreversible neurological damageCardiovascular risk factorsSARS-CoV-2 infectionAntithrombotic regimenCord infarctionHypercoagulable stateSystemic symptomsLymphoma cellsSkin biopsiesLymphomaMalignant processStroke risk factorsEarly diagnosisNeurological damageCherry angiomasIschemic strokeSARS-CoV-2